Mercedes-Benz Becomes Partner Of Automotive Cells Company - Quick Facts

Mercedes-Benz has joined Automotive Cells Company as an equal shareholder along with Stellantis (STLA) and TotalEnergies (TTA.L,TTFNF.PK - DELETED, TOT), holding 1/3 equity stake. As a result, the partners will accelerate ACC's development with an objective of at least 120 GWh of cell capacity by 2030.

Automotive Cells Company (ACC) was founded in August 2020 from the initiative by Stellantis and TotalEnergies to become a European market leader for car batteries.

Källenius, CEO of Daimler AG and Mercedes-Benz AG, said: "This new partnership allows us to secure supply, to take advantage of economies of scale, and to provide our customers with superior battery technology."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mukilteo, Washington-based Ivar's Soup and Sauce Co. is recalling 14,968 sleeves of refrigerated Kettle Classic Clam Chowder With Uncured Bacon citing the possible presence of hard, sharp opaque plastic pieces, the U.S Foof and Drug Administration said. The products were sold exclusively at Costco stores. The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines.
Follow RTT